4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-006287
CVP, Chief Financial Officer sold 5,625 shares at $90.45 ($508,803)
- CVP, Chief Financial Officer acquired 5,625 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ullem Scott B. CVP, Chief Financial Officer | 2024-05-21 | Option exercise 10b5-1 | +5,625 | $45.28 | $254,681 | 36,186 | D: show line 1 in the form |
| Ullem Scott B. CVP, Chief Financial Officer | 2024-05-21 | Sale 10b5-1 | −5,625 | $90.45 | $508,803 | 30,561 | D: show line 2 in the form |
| Open-market sales · 5,625 sh · avg $90.45 · $508,803 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Ullem Scott B. CVP, Chief Financial Officer | 2024-05-21 | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,625 | 61,875 | D: show line 3 in the form |
Loading xslF345X05/doc4.xml…